One of the more spurious and naive arguments proffered by the industry's antagonists and even some people in government is that the pricing of new treatments should reflect whether public funding contributed in any way to its development. …
Latest Video
New Stories
-
Data shows invasive pneumococcal disease at highest level in 15 years
November 13, 2024 - - Latest News -
Arthritis experts launch the ATLAS arthritis eLearning program for health professionals
November 13, 2024 - - Latest News -
Pharmac to fund new heart medicine for 18,000 New Zealanders
November 12, 2024 - - Latest News -
'If you read it, actually, it's a cap on the number of applications that can be considered in the future'
November 12, 2024 - - Latest News -
The Pharmacy Guild welcomes free RSV vaccine decision
November 12, 2024 - - Latest News -
Sandoz celebrates the 5th annual global biosimilars week
November 12, 2024 - - Latest News -
Medical device sector pushes for the adoption of health department 'service standards'
November 12, 2024 - - Latest News